Detalhe da pesquisa
1.
TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation.
Immunity
; 56(7): 1631-1648.e10, 2023 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37392737
2.
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.
Immunity
; 53(4): 824-839.e10, 2020 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33053331
3.
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making.
Hepatology
; 2023 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37300379
4.
Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma.
Int J Mol Sci
; 21(11)2020 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32481768
5.
MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages.
Cancer Res
; 83(4): 626-640, 2023 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36525476
6.
Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth.
Blood Adv
; 6(2): 672-678, 2022 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34714910
7.
Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors.
J Mol Cell Biol
; 12(3): 202-215, 2020 04 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31504643
8.
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression.
J Immunother Cancer
; 8(1)2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32503947